0000000000803390

AUTHOR

Dominik Drobiński

showing 2 related works from this author

Prognostic factors for non-asphyxia-related cardiac arrest patients undergoing extracorporeal rewarming - HELP Registry Study

2020

Objective: Extracorporeal rewarming is the treatment of choice for patients who had hypothermic cardiac arrest, allowing for best neurologic outcome. The authors’ goal was to identify factors associated with survival in nonasphyxia-related hypothermic cardiac arrest patients undergoing extracorporeal rewarming. Design: All 38 cardiac surgery departments in Poland were encouraged to report consecutive hypothermic cardiac arrest patients treated with extracorporeal life support. All variables collected were analyzed in order to compare survivor and nonsurvivor groups. The parameters available at the initiation of extracorporeal rewarming were considered as potential predictors of survival in …

extracorporeal circulationmedicine.medical_specialtycardiac arrestHypothermia030204 cardiovascular system & hematologyhyperlactatemiaExtracorporeallaw.invention03 medical and health sciences0302 clinical medicine030202 anesthesiologylawHumansMedicineRegistriesRewarmingSurvival rateRetrospective StudiesUnivariate analysisbusiness.industryExtracorporeal circulationRetrospective cohort studyout-of-hospitalPrognosisIntensive care unitCardiopulmonary ResuscitationHeart ArrestCardiac surgeryAnesthesiology and Pain MedicineLife supportAnesthesiaPolandCardiology and Cardiovascular Medicinebusiness
researchProduct

Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multi…

2021

Extracorporeal membrane oxygenation (ECMO) requires constant management of coagulation. Whereas unfractionated heparin remains the anticoagulant of choice, experienced centers report high bleeding rates. Biocompatibility of the extracorporeal circuit enables management of anticoagulation with subcutaneous low-molecular-weight heparins only. The aim of this study was to evaluate the safety and feasibility of anticoagulation with subcutaneous nadroparin compared with unfractionated heparin during respiratory ECMO in patients. We assessed for thrombotic complications and number of bleeding and life-threatening bleeding events. Additionally, we evaluated the change in resistance to flow in the …

AdultMalemedicine.drug_classmedicine.medical_treatmentBiomedical EngineeringBiophysicsBioengineering030204 cardiovascular system & hematologyExtracorporealBiomaterials03 medical and health sciencesExtracorporeal Membrane Oxygenation0302 clinical medicineExtracorporeal membrane oxygenationmedicineHumansanticoagulationOxygenatorRetrospective Studiesextracorporeal oxygenationHeparinbusiness.industryAnticoagulantAnticoagulantsThrombosisRetrospective cohort studyGeneral MedicineHeparinMiddle Agedunfractionated heparin030228 respiratory systemCoagulationAnesthesiaNadroparinnadroparinFemalebusinessmedicine.drugASAIO Journal
researchProduct